The below two superb videos from Japan’s Shiseido were shared by its Canadian partner Replicel three weeks ago. I delayed embedding them here until they had English subtitles (which they now do if you click on CC in the lower right corner of the videos). Some of the visuals are very interesting and instructive. In my opinion, if final clinical trials this year work out as expected, Shiseido will be able to bring this technology to fruition far more rapidly and easily in comparison to Replicel due to two main reasons:
- Japan’s newer much more friendlier regulations governing regenerative medicine and stem cell research. Stage 3 clinical trials will no longer be required in Japan.
- Shiseido’s drastically larger size and funding availability in comaprison to Replicel. According to wikipedia, Shiseido is the largest cosmetics firm in Japan, and the fourth largest cosmetics firm in the world.